Effective local therapy and long-term survival in breast cancer - PubMed (original) (raw)
Affiliations
- PMID: 19711579
Free article
Effective local therapy and long-term survival in breast cancer
Karen M Winkfield et al. Oncology (Williston Park). 2009 Jul.
Free article
Abstract
The causal link between local control and long-term survival in breast cancer has become clearer over the past few years. Although the prevalence of breast cancer is high, there has been a steady decline in breast cancer mortality since the early 1990s. Improvements in breast cancer-specific mortality are the result of greater emphasis on cancer screening and improved treatment modalities, principally the development of effective adjuvant systemic therapy. Adjuvant radiation therapy (RT) substantially reduces local recurrence rates, and this reduction is even greater when combined with systemic therapy. Randomized controlled trials and meta-analyses have shown that reducing local recurrence improves overall long-term survival following both mastectomy and breast-conserving therapy. Clinical and translational research has begun to shed light on new prognostic and predictive markers that can assist in the assessment of an individual patient's risk of local recurrence without RT and the likelihood of a survival benefit with RT. The ability to appropriately tailor therapy to reduce local recurrence rates is vital toward continuing the decline in breast cancer mortality.
Comment in
- Local therapy matters.
Parikh RR, Haffty BG. Parikh RR, et al. Oncology (Williston Park). 2009 Jul;23(8):675-6. Oncology (Williston Park). 2009. PMID: 19711580 No abstract available. - Deemphasize dogma: consider the local control-overall survival link.
Zellars RC. Zellars RC. Oncology (Williston Park). 2009 Jul;23(8):679-80. Oncology (Williston Park). 2009. PMID: 19711581 No abstract available.
Similar articles
- 259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.
Di Saverio S, Catena F, Santini D, Ansaloni L, Fogacci T, Mignani S, Leone A, Gazzotti F, Gagliardi S, De Cataldis A, Taffurelli M. Di Saverio S, et al. Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9. Breast Cancer Res Treat. 2008. PMID: 17687650 Review. - Abbreviated course of radiotherapy (RT) for breast cancer.
Schoenfeld JD, Harris JR. Schoenfeld JD, et al. Breast. 2011 Oct;20 Suppl 3:S116-27. doi: 10.1016/S0960-9776(11)70308-3. Breast. 2011. PMID: 22015277 Review. - Who should not undergo breast conservation?
Nijenhuis MV, Rutgers EJ. Nijenhuis MV, et al. Breast. 2013 Aug;22 Suppl 2:S110-4. doi: 10.1016/j.breast.2013.07.021. Breast. 2013. PMID: 24074770 Review. - DEGRO practical guidelines for radiotherapy of breast cancer I: breast-conserving therapy.
Sautter-Bihl ML, Budach W, Dunst J, Feyer P, Haase W, Harms W, Sedlmayer F, Souchon R, Wenz F, Sauer R; German Society of Radiation Oncology; German Cancer Society. Sautter-Bihl ML, et al. Strahlenther Onkol. 2007 Dec;183(12):661-6. doi: 10.1007/s00066-007-1811-1. Strahlenther Onkol. 2007. PMID: 18040609
Cited by
- Overcoming endocrine resistance in metastatic breast cancer: Current evidence and future directions.
Milani A, Geuna E, Mittica G, Valabrega G. Milani A, et al. World J Clin Oncol. 2014 Dec 10;5(5):990-1001. doi: 10.5306/wjco.v5.i5.990. World J Clin Oncol. 2014. PMID: 25493235 Free PMC article. Review. - Recent advances in the development of breast cancer vaccines.
Milani A, Sangiolo D, Aglietta M, Valabrega G. Milani A, et al. Breast Cancer (Dove Med Press). 2014 Oct 14;6:159-68. doi: 10.2147/BCTT.S38428. eCollection 2014. Breast Cancer (Dove Med Press). 2014. PMID: 25339848 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous